BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 17666911)

  • 1. Rho kinase (ROCK) inhibitors.
    Liao JK; Seto M; Noma K
    J Cardiovasc Pharmacol; 2007 Jul; 50(1):17-24. PubMed ID: 17666911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does it matter whether or not a lipid-lowering agent inhibits Rho kinase?
    Liao JK
    Curr Atheroscler Rep; 2007 Nov; 9(5):384-8. PubMed ID: 18001621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2015 ATVB Plenary Lecture: translational research on rho-kinase in cardiovascular medicine.
    Shimokawa H; Satoh K
    Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1756-69. PubMed ID: 26069233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Rho-kinase inhibitors for cardiovascular medicine.
    Shimokawa H; Rashid M
    Trends Pharmacol Sci; 2007 Jun; 28(6):296-302. PubMed ID: 17482681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rho kinase inhibitors: potential treatments for diabetes and diabetic complications.
    Zhou H; Li YJ
    Curr Pharm Des; 2012; 18(20):2964-73. PubMed ID: 22571664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rho-kinase inhibition: a novel therapeutic target for the treatment of cardiovascular diseases.
    Dong M; Yan BP; Liao JK; Lam YY; Yip GW; Yu CM
    Drug Discov Today; 2010 Aug; 15(15-16):622-9. PubMed ID: 20601092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rho-associated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular disease.
    Zhou Q; Gensch C; Liao JK
    Trends Pharmacol Sci; 2011 Mar; 32(3):167-73. PubMed ID: 21242007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis.
    Sawada N; Liao JK
    Antioxid Redox Signal; 2014 Mar; 20(8):1251-67. PubMed ID: 23919640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological role of ROCKs in the cardiovascular system.
    Noma K; Oyama N; Liao JK
    Am J Physiol Cell Physiol; 2006 Mar; 290(3):C661-8. PubMed ID: 16469861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ROCKs as therapeutic targets in cardiovascular diseases.
    Rikitake Y; Liao JK
    Expert Rev Cardiovasc Ther; 2005 May; 3(3):441-51. PubMed ID: 15889972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rho-kinase: important new therapeutic target in cardiovascular diseases.
    Satoh K; Fukumoto Y; Shimokawa H
    Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H287-96. PubMed ID: 21622831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RhoA/Rho-Kinase in the Cardiovascular System.
    Shimokawa H; Sunamura S; Satoh K
    Circ Res; 2016 Jan; 118(2):352-66. PubMed ID: 26838319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rho kinase inhibitors as potential therapeutic agents for cardiovascular diseases.
    Hu E; Lee D
    Curr Opin Investig Drugs; 2003 Sep; 4(9):1065-75. PubMed ID: 14582450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of Rho kinase isoforms in lung endothelial cells during inflammation.
    Mong PY; Wang Q
    J Immunol; 2009 Feb; 182(4):2385-94. PubMed ID: 19201893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosis.
    Knipe RS; Tager AM; Liao JK
    Pharmacol Rev; 2015; 67(1):103-17. PubMed ID: 25395505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rho Kinases and Cardiac Remodeling.
    Shimizu T; Liao JK
    Circ J; 2016 Jun; 80(7):1491-8. PubMed ID: 27251065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rho kinase as a therapeutic target in cardiovascular disease.
    Surma M; Wei L; Shi J
    Future Cardiol; 2011 Sep; 7(5):657-71. PubMed ID: 21929346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Light and Dark of Reactive Oxygen Species for Vascular Function: 2014 ASVB (Asian Society of Vascular Biology).
    Shimokawa H; Satoh K
    J Cardiovasc Pharmacol; 2015 May; 65(5):412-8. PubMed ID: 25162437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular rho kinases and their potential therapeutic applications.
    Budzyn K; Sobey CG
    Curr Opin Drug Discov Devel; 2007 Sep; 10(5):590-6. PubMed ID: 17786858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the development of Rho-associated protein kinase (ROCK) inhibitors.
    Pan P; Shen M; Yu H; Li Y; Li D; Hou T
    Drug Discov Today; 2013 Dec; 18(23-24):1323-33. PubMed ID: 24076262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.